JPWO2021034627A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021034627A5 JPWO2021034627A5 JP2022509051A JP2022509051A JPWO2021034627A5 JP WO2021034627 A5 JPWO2021034627 A5 JP WO2021034627A5 JP 2022509051 A JP2022509051 A JP 2022509051A JP 2022509051 A JP2022509051 A JP 2022509051A JP WO2021034627 A5 JPWO2021034627 A5 JP WO2021034627A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- heteroaralkyl
- aralkyl
- heteroaryl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962887732P | 2019-08-16 | 2019-08-16 | |
| US62/887,732 | 2019-08-16 | ||
| PCT/US2020/046269 WO2021034627A1 (en) | 2019-08-16 | 2020-08-14 | Small molecule stimulators of the core particle of the proteasome |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022544536A JP2022544536A (ja) | 2022-10-19 |
| JP2022544536A5 JP2022544536A5 (https=) | 2023-06-15 |
| JPWO2021034627A5 true JPWO2021034627A5 (https=) | 2023-06-15 |
| JP7583027B2 JP7583027B2 (ja) | 2024-11-13 |
Family
ID=74659522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509051A Active JP7583027B2 (ja) | 2019-08-16 | 2020-08-14 | プロテアソームのコア粒子の低分子刺激物質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220267280A1 (https=) |
| EP (1) | EP4013405A4 (https=) |
| JP (1) | JP7583027B2 (https=) |
| CN (1) | CN114222573A (https=) |
| WO (1) | WO2021034627A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113620881A (zh) * | 2021-08-12 | 2021-11-09 | 浙江禾本科技股份有限公司 | 一种1-[2-(2,4-二氯苯基)-2羟基乙基]-1h咪唑的合成方法 |
| WO2023036936A1 (en) | 2021-09-09 | 2023-03-16 | Booster Therapeutics Gmbh | Bifunctional molecules as proteasome stimulators for improved targeted protein degradation, and their uses as targeted boosting degraders (tarbods) |
| EP4147723A1 (en) | 2021-09-09 | 2023-03-15 | Booster Therapeutics GmbH | Bifunctional molecules as proteasome stimulators for improved targeted protein degradation, and their uses as targeted boosting degraders (tarbods) |
| WO2025219559A1 (en) | 2024-04-18 | 2025-10-23 | Booster Therapeutics Gmbh | Pyrrolidine compounds as proteasome stimulators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU557755A3 (ru) * | 1968-08-19 | 1977-05-05 | Янссен Фармасьютика Н.В. (Фирма) | Способ получени производных имидазола |
| US3991202A (en) * | 1974-01-31 | 1976-11-09 | Janssen Pharmaceutica N.V. | Imidazolium salts |
| US5633274A (en) * | 1993-02-18 | 1997-05-27 | President And Fellows Of Harvard College | Cancer treatments |
| EP0829478A3 (en) * | 1996-09-09 | 1998-03-25 | F. Hoffmann-La Roche Ag | N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents |
| NZ328607A (en) * | 1996-09-09 | 1999-08-30 | Hoffmann La Roche | Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions |
| JPWO2004022546A1 (ja) * | 2002-09-04 | 2006-03-02 | 敬銘 王 | ジャスモン酸の生合成を阻害する物質 |
| MX2007016186A (es) * | 2005-06-14 | 2008-03-07 | Schering Corp | Preparacion y uso de inhibidores de proteasas. |
| BRPI0904249B1 (pt) * | 2009-08-28 | 2018-03-06 | Biolab Sanus Farmacêutica Ltda. | Compostos éteres aralquil benzílicos, processo de preparação dos mesmos, uso dos referidos compostos, composição farmacêutica |
| US11197862B2 (en) * | 2015-07-16 | 2021-12-14 | Xomics Biopharma, Inc. | Methods of preventing toxicity of platinum drugs |
-
2020
- 2020-08-14 US US17/627,527 patent/US20220267280A1/en active Pending
- 2020-08-14 CN CN202080057165.6A patent/CN114222573A/zh active Pending
- 2020-08-14 WO PCT/US2020/046269 patent/WO2021034627A1/en not_active Ceased
- 2020-08-14 JP JP2022509051A patent/JP7583027B2/ja active Active
- 2020-08-14 EP EP20855334.7A patent/EP4013405A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018519302A5 (https=) | ||
| JP2020169171A5 (https=) | ||
| JP2020503374A5 (https=) | ||
| JP2019510039A5 (https=) | ||
| JP2017524025A5 (https=) | ||
| JP2020503010A5 (https=) | ||
| JP2015509535A5 (https=) | ||
| JP2020503009A5 (https=) | ||
| JP2019518050A5 (https=) | ||
| JP2020511943A5 (https=) | ||
| JP2020537501A5 (https=) | ||
| JP2010501003A5 (https=) | ||
| JP2014500295A5 (https=) | ||
| JP2008505157A5 (https=) | ||
| JP2022506111A5 (https=) | ||
| EA200500846A1 (ru) | Замещенные арилтиомочевины и родственные соединения; ингибиторы вирусной репликации | |
| RU2013147744A (ru) | Дозированная лекарственная форма для перорального применения | |
| JPWO2008099874A1 (ja) | ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法 | |
| RU2008108887A (ru) | Жидкие составы | |
| JP2005511699A5 (https=) | ||
| JP2019527724A5 (https=) | ||
| JP2019520344A5 (https=) | ||
| JP2019518034A5 (https=) | ||
| JP2018522927A5 (https=) | ||
| JP2020111571A5 (https=) |